CytoSorbents announces the appointment of Peter J. Mariani as Chief Financial Officer CFO , effective August 1. Mr. Mariani will report to Dr. Phillip Chan, Chief Executive Officer of CytoSorbents. Concurrently, Kathleen P. Bloch, CytoSorbents’ current CFO, announced her retirement from the Company effective as of the close of business today, and will continue to serve in an advisory role as a consultant to enable an effective transition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSO:
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
- CytoSorbents Regains Compliance, Continues on Nasdaq
- CytoSorbents regains compliance with Nasdaq min bid price requirement
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website